Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/IIa malaria sporozoite challenge of ChAd63/MVA ME-TRAP and CS vaccines
2011-005477-24Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2012
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ChAd63 CS, MVA-CS, ChAd63 ME-TRAP, MVA ME-TRAP in Falciparum malaria (PF), malaria, sponsored by University of Oxford. Started Jan 2012; status: completed.
02
Drugs
ChAd63 CSMVA-CSChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
Falciparum malaria (PF)malaria
Beyond the preview
Go deeper on 2011-005477-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005477-24.